16-18793089-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015161.3(ARL6IP1):c.*163A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0966 in 547,234 control chromosomes in the GnomAD database, including 2,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.097 ( 767 hom., cov: 33)
Exomes 𝑓: 0.096 ( 2122 hom. )
Consequence
ARL6IP1
NM_015161.3 3_prime_UTR
NM_015161.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.22
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-18793089-T-C is Benign according to our data. Variant chr16-18793089-T-C is described in ClinVar as [Benign]. Clinvar id is 1231012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.*163A>G | 3_prime_UTR_variant | 6/6 | ENST00000304414.12 | NP_055976.1 | ||
ARL6IP1 | NM_001313858.1 | c.*163A>G | 3_prime_UTR_variant | 6/6 | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.*163A>G | 3_prime_UTR_variant | 6/6 | 1 | NM_015161.3 | ENSP00000306788 | P1 | ||
ARL6IP1 | ENST00000563861.5 | c.*357A>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ENSP00000456596 | ||||
ARL6IP1 | ENST00000546206.6 | c.*163A>G | 3_prime_UTR_variant | 6/6 | 2 | ENSP00000440048 | ||||
ARL6IP1 | ENST00000562819.5 | c.*163A>G | 3_prime_UTR_variant | 3/3 | 5 | ENSP00000457372 |
Frequencies
GnomAD3 genomes AF: 0.0975 AC: 14836AN: 152166Hom.: 769 Cov.: 33
GnomAD3 genomes
AF:
AC:
14836
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0962 AC: 37999AN: 394950Hom.: 2122 Cov.: 4 AF XY: 0.0984 AC XY: 20756AN XY: 210962
GnomAD4 exome
AF:
AC:
37999
AN:
394950
Hom.:
Cov.:
4
AF XY:
AC XY:
20756
AN XY:
210962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0975 AC: 14846AN: 152284Hom.: 767 Cov.: 33 AF XY: 0.100 AC XY: 7475AN XY: 74466
GnomAD4 genome
AF:
AC:
14846
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
7475
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
438
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at